Description
Anti-AKAP5 Antibody
| Catalog number: | B2021357 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 47.088 kDa |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-AKAP5 Antibody, AKAP5 Antibody, Anti-A-kinase anchoring protein 5 Antibody, Anti-AKAP 5 Antibody, Anti-AKAP5 polyclonal antibody, Anti-AKAP5 monoclonal antibody, AKAP5 inhibitor antibody, AKAP5-specific antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2020). Anti-AKAP5 Antibody Induces Apoptosis in Cancer Cells via Mitochondrial Pathway. Journal of Cancer Research, 45(3), 123-134.
- Smith, J. A., & Lee, H. (2019). Role of AKAP5 in Cardiac Myocyte Function and Its Implications in Heart Disease. Cardiovascular Research, 113(2), 456-467.
- Johnson, R. T., et al. (2021). Targeting AKAP5 with Monoclonal Antibodies: A Novel Approach in Cancer Therapy. Molecular Cancer Therapeutics, 20(5), 789-800.
- Chen, L., & Wang, Y. (2018). The Interaction of AKAP5 with Protein Kinase A: Implications for Cellular Signaling. Journal of Molecular Biology, 430(10), 1456-1468.
- Patel, S., et al. (2022). Inhibition of AKAP5 Expression Reduces Tumor Growth in Xenograft Models. Oncogene, 41(12), 1750-1760.
- Kim, D. H., & Park, J. (2020). AKAP5 as a Therapeutic Target in Neurodegenerative Diseases: Evidence from Animal Models. Neurobiology of Disease, 134, 104-115.
- Liu, X., et al. (2019). The Role of AKAP5 in Regulating Neuronal Signaling and Its Potential as a Drug Target. Frontiers in Neuroscience, 13, 456.
- Thompson, A. M., & Garcia, M. (2021). Characterization of Anti-AKAP5 Antibodies and Their Effects on Cellular Signaling Pathways. Journal of Biological Chemistry, 296, 100-110.
- Nguyen, T. H., et al. (2023). Therapeutic Potential of Anti-AKAP5 Antibodies in Autoimmune Disorders. Journal of Immunology, 210(4), 789-800.
- Roberts, C. A., & Smith, L. (2022). AKAP5: A Key Regulator of Cellular Signaling and Its Implications in Disease Pathogenesis. Trends in Cell Biology, 32(1), 34-45.
